BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
I-Ping Yang, Zhi-Feng Miao, Ching-Wen Huang, Hsiang-Lin Tsai, Yung-Sung Yeh, Wei-Chih Su, Tsung-Kun Chang, Se-fen Chang, Jaw-Yuan Wang. High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapyTherapeutic Advances in Medical Oncology 2019; 11: 175883591986696 doi: 10.1177/1758835919866964
2
Jiehong Kong, Weipeng Wang. <p>A Systemic Review on the Regulatory Roles of miR-34a in Gastrointestinal Cancer</p>OncoTargets and Therapy 2020; : 2855 doi: 10.2147/OTT.S234549
3
Veronika Vymetalkova, Pavel Vodicka, Sona Vodenkova, Sergio Alonso, Regine Schneider-Stock. DNA methylation and chromatin modifiers in colorectal cancerMolecular Aspects of Medicine 2019; 69: 73 doi: 10.1016/j.mam.2019.04.002
4
Mariangela De Robertis, Maria Luana Poeta, Emanuela Signori, Vito Michele Fazio. Current understanding and clinical utility of miRNAs regulation of colon cancer stem cellsSeminars in Cancer Biology 2018; 53: 232 doi: 10.1016/j.semcancer.2018.08.008
5
Stamatia-Maria Rapti, Christos K. Kontos, Spyridon Christodoulou, Iordanis N. Papadopoulos, Andreas Scorilas. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic valueClinical Biochemistry 2017; 50(16-17): 918 doi: 10.1016/j.clinbiochem.2017.06.004
6
Colorectal Cancer and Alcohol Consumption—Populations to MoleculesCancers 2018; 10(2): 38 doi: 10.3390/cancers10020038
7
Atena Soleimani, Majid Khazaei, Gordon A Ferns, Mikhail Ryzhikov, Amir Avan, Seyed Mahdi Hassanian. Role of TGF‐β signaling regulatory microRNAs in the pathogenesis of colorectal cancerJournal of Cellular Physiology 2019; 234(9): 14574 doi: 10.1002/jcp.28169
8
Lei Ding, Zhenwei Lan, Xianhui Xiong, Hongshun Ao, Yingting Feng, Huan Gu, Min Yu, Qinghua Cui. The Dual Role of MicroRNAs in Colorectal Cancer ProgressionInternational Journal of Molecular Sciences 2018; 19(9): 2791 doi: 10.3390/ijms19092791
9
Xiao Juan Tang, Wei Wang, Swei Sunny Hann. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancerBiochimie 2019; 163: 58 doi: 10.1016/j.biochi.2019.05.010
10
Zhi-Hua Li, Xueling Weng, Qiu-Yun Xiong, Jian-Hong Tu, An Xiao, Wei Qiu, Yu Gong, Er-Wei Hu, Songyin Huang, Ya-Li Cao. miR-34a expression in human breast cancer is associated with drug resistanceOncotarget 2017; 8(63): 106270 doi: 10.18632/oncotarget.22286
11
Ion Cristóbal, Blanca Torrejón, Andrea Santos, Melani Luque, Marta Sanz-Alvarez, Federico Rojo, Jesús García-Foncillas. Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancerEuropean Journal of Surgical Oncology 2018; 44(8): 1283 doi: 10.1016/j.ejso.2018.04.021
12
Alexandra Gherman, Loredana Balacescu, Sinziana Gheorghe-Cetean, Catalin Vlad, Ovidiu Balacescu, Alexandru Irimie, Cosmin Lisencu. Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as BiomarkersInternational Journal of Molecular Sciences 2020; 21(6): 2089 doi: 10.3390/ijms21062089
13
Wu Wei, Yang Xi, Xu Jiamin, Zhuang Jing, Han Shuwen. Screening of molecular targets and construction of a ceRNA network for oxaliplatin resistance in colorectal cancerRSC Advances 2019; 9(54): 31413 doi: 10.1039/C9RA06146K
14
Madhav Madurantakam Royam, Chellan Kumarasamy, Siddhartha Baxi, Ajay Gupta, Nachimuthu Ramesh, Gothandam Kodiveri Muthukaliannan, Rama Jayaraj. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical StudiesMolecular Diagnosis & Therapy 2019; 23(1): 65 doi: 10.1007/s40291-019-00381-6
15
Fei Li, Xinji Li, Li Qiao, Wen Liu, Chengshan Xu, Xiaogang Wang. MALAT1 regulates miR-34a expression in melanoma cellsCell Death & Disease 2019; 10(6) doi: 10.1038/s41419-019-1620-3
16
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Fardin Hashemi, Saeed Samarghandian, Masoud Najafi. MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancerLife Sciences 2020; 256: 117973 doi: 10.1016/j.lfs.2020.117973
17
Grzegorz Hibner, Małgorzata Kimsa-Furdzik, Tomasz Francuz. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal CancerInternational Journal of Molecular Sciences 2018; 19(10): 2944 doi: 10.3390/ijms19102944
18
Jiabei Zhou, Yu Kang, Lu Chen, Hua Wang, Junqing Liu, Su Zeng, Lushan Yu. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor AgentsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00343
19
Sanaz Naghizadeh, Ali Mohammadi, Pascal H. G. Duijf, Behzad Baradaran, Elham Safarzadeh, William Chi‐Shing Cho, Behzad Mansoori. The role of miR‐34 in cancer drug resistanceJournal of Cellular Physiology 2020;  doi: 10.1002/jcp.29640
20
Ping Zhao, Yu-guang Ma, Yang Zhao, Di Liu, Zhi-jun Dai, Chang-you Yan, Hai-tao Guan. MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancerCancer Chemotherapy and Pharmacology 2019; 84(2): 427 doi: 10.1007/s00280-019-03866-7
21
Andrew J. Pellatt, Lila E. Mullany, Jennifer S. Herrick, Lori C. Sakoda, Roger K. Wolff, Wade S. Samowitz, Martha L. Slattery. The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAsJournal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1566-8
22
Yanqiu Wang, Jun Xiang, Jianjun Wang, Yazhong Ji. Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signalingBiological Research 2018; 51(1) doi: 10.1186/s40659-018-0205-4
23
Gerhard Jung, Eva Hernández-Illán, Leticia Moreira, Francesc Balaguer, Ajay Goel. Epigenetics of colorectal cancer: biomarker and therapeutic potentialNature Reviews Gastroenterology & Hepatology 2020; 17(2): 111 doi: 10.1038/s41575-019-0230-y
24
Yun Zhang, Hongmei Tang, Xiefang Yuan, Qin Ran, Xiaoyun Wang, Qi Song, Lei Zhang, Yuhuan Qiu, Xing Wang. TGF-β3 Promotes MUC5AC Hyper-Expression by Modulating Autophagy Pathway in Airway EpitheliumEBioMedicine 2018; 33: 242 doi: 10.1016/j.ebiom.2018.06.032
25
Atena Soleimani, Mehran Pashirzad, Amir Avan, Gordon A. Ferns, Majid Khazaei, Seyed Mahdi Hassanian. Role of the transforming growth factor‐β signaling pathway in the pathogenesis of colorectal cancerJournal of Cellular Biochemistry 2019; 120(6): 8899 doi: 10.1002/jcb.28331
26
Reyhaneh Moradi-Marjaneh, Majid Khazaei, Gordon A. Ferns, Seyed H. Aghaee-Bakhtiari. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal CancerCurrent Pharmaceutical Design 2019; 24(39): 4611 doi: 10.2174/1381612825666190110150705
27
Xin Tian, Guangwei Zhang, Hui Zhao, Yang Li, Chaoyang Zhu. Long non-coding RNA NEAT1 contributes to docetaxel resistance of prostate cancer through inducing RET expression by sponging miR-34aRSC Advances 2017; 7(68): 42986 doi: 10.1039/C7RA06107B
28
Qun Li, Wei Song, Jianmin Wang. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2Biomedicine & Pharmacotherapy 2019; 109: 1793 doi: 10.1016/j.biopha.2018.11.003
29
Reyhaneh Moradi Marjaneh, Majid Khazaei, Gordon A. Ferns, Amir Avan, Seyed Hamid Aghaee‐Bakhtiari. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implicationIUBMB Life 2019; 71(10): 1428 doi: 10.1002/iub.2108
30
Stergios Boussios, Mehmet Akif Ozturk, Michele Moschetta, Afroditi Karathanasi, Nikolaos Zakynthinakis-Kyriakou, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Nicholas Pavlidis. The Developing Story of Predictive Biomarkers in Colorectal CancerJournal of Personalized Medicine 2019; 9(1): 12 doi: 10.3390/jpm9010012
31
Kenneth KW To, Christy WS Tong, Mingxia Wu, William CS Cho. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedsideWorld Journal of Gastroenterology 2018; 24(27): 2949-2973 doi: 10.3748/wjg.v24.i27.2949
32
Zhen-Hua Yang, Yan-Qi Dang, Guang Ji. Role of epigenetics in transformation of inflammation into colorectal cancerWorld Journal of Gastroenterology 2019; 25(23): 2863-2877 doi: 10.3748/wjg.v25.i23.2863
33
Teng Lv, Kejuan Song, Lili Zhang, Weihua Li, Yulong Chen, Yuchao Diao, Qin Yao, Peishu Liu. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1Biochemistry and Cell Biology 2018; 96(5): 663 doi: 10.1139/bcb-2018-0031
34
Xijuan Chen, Junqi Liu, Qinglan Zhang, Baoxing Liu, Yan Cheng, Yonglei Zhang, Yanan Sun, Hong Ge, Yingqiang Liu. Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-019-1507-2
35
Ammad Farooqi, Sobia Tabassum, Aamir Ahmad. MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different CancersInternational Journal of Molecular Sciences 2017; 18(10): 2089 doi: 10.3390/ijms18102089
36
Li Zhang, Hao Niu, Jie Ma, Bao-Ying Yuan, Yu-Han Chen, Yuan Zhuang, Gen-Wen Chen, Zhao-Chong Zeng, Zuo-Lin Xiang. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinomaMolecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1044-9
37
Yu‐Zhu Wu, Hong‐Yue Lin, Yin Zhang, Wen‐Fa Chen. miR‐200b‐3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancerThe Journal of Gene Medicine 2020; 22(7) doi: 10.1002/jgm.3178
38
Chixiong Huang, Senlin Huang, Hairui Li, Xinzhong Li, Bing Li, Lintao Zhong, Junfeng Wang, Meishen Zou, Xiang He, Hao Zheng, Xiaoyun Si, Wangjun Liao, Yulin Liao, Li Yang, Jianping Bin. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivoJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0900-6